Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-064982

Director bought 500 shares at $1.98 ($990)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nanavaty Maulik Director 2023-11-16 Purchase +500 $1.98 $990 500 D
Open-market purchases · 500 sh · avg $1.98 · $990
Loading xslF345X05/ownership.xml…